MAPT and Alzheimer disease: Our cytokine analyses results on the 3xTg AD mouse brains further corroborate the effects observed on reducing the full-length mutant hAPP, Aβ1-42, and unphosphorylated and phosphorylated human tau, further reinforce the notion that the nanoparticles alone and F12511 produced additive effects.